Dennis Huang
Chief Tech/Sci/R&D Officer bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Gegenwärtig hat Dennis Karl Huang die Position des Chief Technical Operations Officer & Senior VP bei Ultragenyx Pharmaceutical, Inc. inne. Herr Huang ist außerdem Mitglied des Vorstands von Bonti, Inc. In der Vergangenheit hatte er die Position des VP-Biologics Manufacturing & Development bei Allergan, Inc. und des Senior VP-Manufacturing & Supply Chain bei InterMune, Inc. inne. Herr Huang erwarb einen Bachelor-Abschluss am Knox College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.03.2024 | 83 002 ( 0,10% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Dennis Huang
Unternehmen | Position | Beginn |
---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 01.05.2015 |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Director/Board Member | - |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology CytoDel LLC is engaged in biotechnology services. Its products include Ctyo-111, first botulism antidote and Cyto-012, musculoskeletal and aesthetic medicine. The company was founded by Philip A. Band, Konstantin Ichtchenko and Edwin Vazquez Cintron in 2012 and is headquartered in New York City, NY. | Director/Board Member | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 28.04.2023 |
Ehemalige bekannte Positionen von Dennis Huang
Unternehmen | Position | Ende |
---|---|---|
INTERMUNE INC | Corporate Officer/Principal | 01.03.2015 |
ALLERGAN, INC. | Corporate Officer/Principal | 01.08.2013 |
Ausbildung von Dennis Huang
Knox College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Health Technology |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology CytoDel LLC is engaged in biotechnology services. Its products include Ctyo-111, first botulism antidote and Cyto-012, musculoskeletal and aesthetic medicine. The company was founded by Philip A. Band, Konstantin Ichtchenko and Edwin Vazquez Cintron in 2012 and is headquartered in New York City, NY. | Health Technology |